187 related articles for article (PubMed ID: 35526049)
1. Elevated transcription and glycosylation of B3GNT5 promotes breast cancer aggressiveness.
Miao Z; Cao Q; Liao R; Chen X; Li X; Bai L; Ma C; Deng X; Dai Z; Li J; Dong C
J Exp Clin Cancer Res; 2022 May; 41(1):169. PubMed ID: 35526049
[TBL] [Abstract][Full Text] [Related]
2. AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis.
Liao R; Chen X; Cao Q; Bai L; Ma C; Dai Z; Dong C
Breast Cancer Res; 2024 Apr; 26(1):70. PubMed ID: 38654332
[TBL] [Abstract][Full Text] [Related]
3. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
4. Loss of ABAT-Mediated GABAergic System Promotes Basal-Like Breast Cancer Progression by Activating Ca
Chen X; Cao Q; Liao R; Wu X; Xun S; Huang J; Dong C
Theranostics; 2019; 9(1):34-47. PubMed ID: 30662552
[TBL] [Abstract][Full Text] [Related]
5. HIST1H1B Promotes Basal-Like Breast Cancer Progression by Modulating CSF2 Expression.
Liao R; Chen X; Cao Q; Wang Y; Miao Z; Lei X; Jiang Q; Chen J; Wu X; Li X; Li J; Dong C
Front Oncol; 2021; 11():780094. PubMed ID: 34746019
[TBL] [Abstract][Full Text] [Related]
6. IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop.
Lei X; Liao R; Chen X; Wang Z; Cao Q; Bai L; Ma C; Deng X; Ma Y; Wu X; Li J; Dai Z; Dong C
Cancer Lett; 2024 Feb; 582():216527. PubMed ID: 38048842
[TBL] [Abstract][Full Text] [Related]
7. ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness.
Werner M; Dyas A; Parfentev I; Schmidt GE; Mieczkowska IK; Müller-Kirschbaum LC; Müller C; Kalkhof S; Reinhardt O; Urlaub H; Alves F; Gallwas J; Prokakis E; Wegwitz F
Cell Death Dis; 2022 Sep; 13(9):762. PubMed ID: 36057630
[TBL] [Abstract][Full Text] [Related]
8. Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal-like Breast Cancer.
Zhang J; Miao N; Lao L; Deng W; Wang J; Zhu X; Huang Y; Lin H; Zeng W; Zhang W; Tan L; Yuan X; Zeng X; Zhu J; Chen X; Song E; Yang L; Nie Y; Huang D
Adv Sci (Weinh); 2024 May; 11(20):e2307660. PubMed ID: 38491910
[TBL] [Abstract][Full Text] [Related]
9. Effect of niclosamide on basal-like breast cancers.
Londoño-Joshi AI; Arend RC; Aristizabal L; Lu W; Samant RS; Metge BJ; Hidalgo B; Grizzle WE; Conner M; Forero-Torres A; Lobuglio AF; Li Y; Buchsbaum DJ
Mol Cancer Ther; 2014 Apr; 13(4):800-11. PubMed ID: 24552774
[TBL] [Abstract][Full Text] [Related]
10. AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program.
Wu X; Li X; Fu Q; Cao Q; Chen X; Wang M; Yu J; Long J; Yao J; Liu H; Wang D; Liao R; Dong C
J Exp Med; 2017 Apr; 214(4):1065-1079. PubMed ID: 28270406
[TBL] [Abstract][Full Text] [Related]
11. SOX10 promotes the malignant biological behavior of basal-like breast cancer cells by regulating EMT process.
Yang K; Yun F; Shi L; Liu X; Jia YF
Heliyon; 2023 Dec; 9(12):e23162. PubMed ID: 38144326
[TBL] [Abstract][Full Text] [Related]
12. The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression.
Shepherd JH; Uray IP; Mazumdar A; Tsimelzon A; Savage M; Hilsenbeck SG; Brown PH
Oncotarget; 2016 Mar; 7(11):13106-21. PubMed ID: 26894864
[TBL] [Abstract][Full Text] [Related]
13. FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.
Jin Y; Han B; Chen J; Wiedemeyer R; Orsulic S; Bose S; Zhang X; Karlan BY; Giuliano AE; Cui Y; Cui X
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S758-66. PubMed ID: 25124473
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
Stratford AL; Habibi G; Astanehe A; Jiang H; Hu K; Park E; Shadeo A; Buys TP; Lam W; Pugh T; Marra M; Nielsen TO; Klinge U; Mertens PR; Aparicio S; Dunn SE
Breast Cancer Res; 2007; 9(5):R61. PubMed ID: 17875215
[TBL] [Abstract][Full Text] [Related]
16. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
[TBL] [Abstract][Full Text] [Related]
17. WNT signaling pathway regulator-
Zhou Y; Li C; Peng J; Luo P; Xie C; Liu S; Chen G; Li T
J Thorac Dis; 2020 Jul; 12(7):3478-3487. PubMed ID: 32802426
[TBL] [Abstract][Full Text] [Related]
18. A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
Du G; Sun J; Li Z; Zhang Q; Liu W; Yang C; Zhao P; Wang X; Yin Q; Luo Y; Song J; Wen Y; Wang H; Chen CH; Hu G; Zhou Z; Mao X; Liu W; Liu Z; Jiang D; Chen C
Cancer Lett; 2022 May; 534():215618. PubMed ID: 35259457
[TBL] [Abstract][Full Text] [Related]
19. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
[TBL] [Abstract][Full Text] [Related]
20. AGR2 and AGR3 play an important role in the clinical characterization and prognosis of basal like breast cancer.
de Moraes CL; Cruz E Melo N; Valoyes MAV; Naves do Amaral W
Clin Breast Cancer; 2022 Feb; 22(2):e242-e252. PubMed ID: 34462207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
